| Literature DB >> 28512454 |
Karlijn C Bastiaansen1,2, Cristina Civantos1, Wilbert Bitter2, María A Llamas1.
Abstract
Cell-surface signaling (CSS) is a signal transfer system that allows Gram-negative bacteria to detect environmental signals and generate a cytosolic response. These systems are composed of an outer membrane receptor that senses the inducing signal, an extracytoplasmic function sigma factor (σECF) that targets the cytosolic response by modifying gene expression and a cytoplasmic membrane anti-sigma factor that keeps the σECF in an inactive state in the absence of the signal and transduces its presence from the outer membrane to the cytosol. Although CSS systems regulate bacterial processes as crucial as stress response, iron scavenging and virulence, the exact mechanisms that drive CSS are still not completely understood. Binding of the signal to the CSS receptor is known to trigger a signaling cascade that results in the regulated proteolysis of the anti-sigma factor and the activation of the σECF in the cytosol. This study was carried out to generate new insights in the proteolytic activation of CSS σECF. We performed a random mutagenesis screen of the unique IutY protein of Pseudomonas putida, a protein that combines a cytosolic σECF domain and a periplasmic anti-sigma factor domain in a single polypeptide. In response to the presence of an iron carrier, the siderophore aerobactin, in the extracellular medium, IutY is processed by two different proteases, Prc and RseP, which results in the release and activation of the σIutY domain. Our experiments show that all IutY mutant proteins that contain periplasmic residues depend on RseP for activation. In contrast, Prc is only required for mutant variants with a periplasmic domain longer than 50 amino acids, which indicates that the periplasmic region of IutY is trimmed down to ~50 amino acids creating the RseP substrate. Moreover, we have identified several conserved residues in the CSS anti-sigma factor family of which mutation leads to constitutive activation of their cognate σECF. These findings advance our knowledge on how CSS activity is regulated by the consecutive action of two proteases. Elucidation of the exact mechanism behind CSS activation will enable the development of strategies to block CSS in pathogenic bacteria.Entities:
Keywords: Pseudomonas; bacterial signal transduction; cell-surface signaling; gene regulation; iron; proteolysis; siderophore; sigma factor
Year: 2017 PMID: 28512454 PMCID: PMC5411451 DOI: 10.3389/fmicb.2017.00747
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Scheme of the proteolytic events that activate the aerobactin-induced Iut CSS system of The two proteins of the system, the IutA CSS receptor and the IutY sigma/anti-sigma hybrid protein are shown. In the absence of the siderophore, the sigma domain of IutY is inactive. (B) Binding of ferric-aerobactin to IutA generates a signal that, by analogy with other CSS systems, is likely transmitted to IutY by the signaling domain of IutA (dark gray ball). This triggers the proteolytic cleavage of the anti-sigma C-domain of IutY by the sequential action of the Prc and the RseP proteases. The resulting σIutY protein domain can then interact with the RNAP and initiates expression of the iutA gene. OM, outer membrane; CM, cytoplasmic membrane. Adapted from Bastiaansen et al. (2014) and Llamas et al. (2014).
Bacterial strains and plasmids used in this study.
| DH5α | Hanahan, | |
| TOP10F′ | F′[ | Invitrogen |
| KT2440 | Franklin et al., | |
| Δ | Markerless KT2440 null mutant in the | Bastiaansen et al., |
| Δ | Markerless KT2440 null mutant in the | Bastiaansen et al., |
| Δ | Markerless KT2440 null mutant in the | Bastiaansen et al., |
| Δ | Markerless KT2440 null mutant in the | This study |
| Δ | Δ | This study |
| Δ | Δ | This study |
| Δ | Δ | This study |
| PAO1 | PAO1 | Mettrick and Lamont, |
| PAO1 | PAO1 | Mettrick and Lamont, |
| pKNG101 | Gene replacement suicide vector, | Kaniga et al., |
| pKΔprc | pKNG101 carrying the | Bastiaansen et al., |
| pKΔrseP | pKNG101 carrying the | Bastiaansen et al., |
| pKΔiutA | pKNG101 carrying in XbaI-BamHI a 2.8-Kb PCR fragment containing the regions up- and downstream the | This study |
| pMMB67EH | IncQ broad-host range plasmid, | Fürste et al., |
| pMMBK1-HA | pMMB67EH carrying an N-terminally HA-tagged | Bastiaansen et al., |
| pMMBK1-HA-168 | pMMBK1-HA in which a premature stop codon was inserted after residue 168 (from the random mutagenesis screen); ApR | This study |
| pMMBK1-HA-201 | pMMBK1-HA in which a premature stop codon was inserted after residue 201 (from the random mutagenesis screen); ApR | This study |
| pMMBK1-HA-260 | pMMBK1-HA in which a premature stop codon was inserted after residue 260 (from the random mutagenesis screen); ApR | This study |
| pMMBK1-HA-318 | pMMBK1-HA in which a premature stop codon was inserted after residue 318 (from the random mutagenesis screen); ApR | This study |
| pMMBK1-HA-365 | pMMBK1-HA in which a premature stop codon was inserted after residue 365 (from the random mutagenesis screen); ApR | This study |
| pMMBK1-HA-225 | pMMB67EH carrying in EcoRI-HindIII a 6.75-Kb PCR fragment encoding the first 225 amino acids of the | This study |
| pMMBK1-HA-236 | pMMB67EH carrying in EcoRI-HindIII a 7.08-Kb PCR fragment encoding the first 236 amino acids of the | This study |
| pMMBK1-HA-293 | pMMB67EH carrying in EcoRI-HindIII a 8.79-Kb PCR fragment encoding the first 293 amino acids of the | This study |
| pMMBK1-HA-338 | pMMB67EH carrying in EcoRI-HindIII a 1.01-Kb PCR fragment encoding the first 338 amino acids of the | This study |
| pMMBK1-HA-G201C | pMMBK1-HA in which glycine-201 has been mutated to a cysteine; ApR | This study |
| pMMBK1-HA-D210A | pMMBK1-HA in which aspartic acid-210 has been mutated to an alanine; ApR | This study |
| pMMBK1-HA-F226L | pMMBK1-HA in which phenylalanine-226 has been mutated to a leucine; ApR | This study |
| pMMBK1-HA-E230K | pMMBK1-HA in which glutamic acid-230 has been mutated to a lysine; ApR | This study |
| pMMBK1-HA-R231Q | pMMBK1-HA in which arginine-231 has been mutated to a glutamine; ApR | This study |
| pMMBK1-HA-A240E | pMMBK1-HA in which alanine-240 has been mutated to a glutamic acid; ApR | This study |
| pMMBK1-HA-F251S | pMMBK1-HA in which phenylalanine-251 has been mutated to a serine; ApR | This study |
| pMMBK1-HA-V253D | pMMBK1-HA in which valine-253 has been mutated to an aspartic acid; ApR | This study |
| pMMBK1-HA-R271C | pMMBK1-HA in which arginine-271 has been mutated to a cysteine; ApR | This study |
| pMMBK1-HA-W301G | pMMBK1-HA in which tryptophan-301 has been mutated to a glycine; ApR | This study |
| pMMBK1-HA-G304D | pMMBK1-HA in which glycine-304 has been mutated to an aspartic acid; ApR | This study |
| pMMBK1-HA-T365I | pMMBK1-HA in which threonine-365 has been mutated to an isoleucine; ApR | This study |
| pMMBK1-HA-LtoP | pMMBK1-HA in which leucine-313, leucine-317 and leucine-320 have been mutated to prolines; ApR | This study |
| pMMB/HA-FoxR | pMMB67EH carrying the | Bastiaansen et al., |
| pMMB/HA-FoxR-D132A | pMMB/HA-FoxR in which aspartic acid-132 has been mutated to an alanine; ApR | This study |
| pMMB/HA-FoxR-R153Q | pMMB/HA-FoxR in which asparagine-153 has been mutated to a glutamine; ApR | This study |
| pMMB/HA-FoxR-V180D | pMMB/HA-FoxR in which valine-180 has been mutated to an aspartic acid; ApR | This study |
| pMMB/HA-FiuR | pMMB67EH carrying in EcoRI-XbaI a 0.97-Kb PCR fragment containing a N-terminally HA-tagged | Bastiaansen et al., |
| pMMB/HA-FiuR-D133A | pMMB/HA-FiuR in which aspartic acid-133 has been mutated to an alanine; ApR | This study |
| pMMB/HA-FiuR-R154Q | pMMB/HA-FiuR in which asparagine-154 has been mutated to a glutamine; ApR | This study |
| pMMB/HA-FiuR-V177D | pMMB/HA-FiuR in which valine-177 has been mutated to an aspartic acid; ApR | This study |
| pMP220 | IncP broad-host-range | Spaink et al., |
| pMPK4 | pMP220 carrying the | Bastiaansen et al., |
| pMPR8b | pMP220 carrying the | Llamas et al., |
| pMPFiuA | pMP220 carrying the | Llamas et al., |
Ap.
Figure 2Activity and processing of constitutively active truncated IutY variants. (A) Schematic representation of the P. putida sigma/anti-sigma hybrid protein IutY drawn to scale. The cytosolic sigma factor domain, transmembrane (TM) domain, and periplasmic anti-sigma factor domain are shown. The number of amino acids of the various truncated variants tested are indicated. (B) β-Galactosidase activity of the P. putida KT2440 wild-type strain (black bars) and its isogenic Δprc (black striped bars) or ΔrseP (white striped bars) mutants bearing the transcriptional fusion iutA::lacZ (pMPK4 plasmid) and a pMMB67EH-derivate expressing one of the indicated truncated IutY variants grown in LB supplemented with 1 mM IPTG. (C) β-Galactosidase activity of the P. putida ΔiutY mutant bearing the transcriptional fusion iutA::lacZ (pMPK4 plasmid) and the pMMB67EH (empty), pMMBK1-HA (WT), pMMBK1-HA-168, -201, -236, or -365 construct expressing one of the IutY variants grown in low iron medium supplemented with 1 mM IPTG in the absence (light gray bars) or presence (dark gray bars) of aerobactin. (D) The P. putida KT2440 wild-type strain (WT) and its isogenic Δprc or ΔrseP mutant expressing one of the indicated truncated IutY variants were grown in LB supplemented with 1 mM IPTG. Proteins were detected by Western-blot using an anti-HA antibody. Position of the full-length truncate protein is indicated by an arrow. The protein band corresponding to the σIutY domain and the molecular size marker (in kDa) are also indicated. Vertical dotted line indicates combination of two separate images to show prolonged exposure of the HA-IutY wild-type protein blot, which was not visible in this condition.
Figure 3Activity and processing of constitutively active IutY point mutants. (A) Schematic representation of the P. putida IutY protein drawn as in Figure 2A. The position of the IutY single mutations tested is indicated. (B) β-Galactosidase activity of the P. putida ΔiutY mutant strain bearing the transcriptional fusion iutA::lacZ (pMPK4 plasmid) and the pMMB67EH (empty, -), pMMBK1-HA (WT), pMMBK1-HA-D210, -R231Q, -A240E, -F251S, -V253D, -W301G, or -LtoP construct expressing the corresponding IutY protein variant grown in low iron medium supplemented with 1 mM IPTG in the absence (light gray bars) or presence (dark gray bars) of aerobactin. (C) The P. putida ΔiutY strain expressing the indicated N-terminally HA-tagged IutY mutant protein was grown in the absence (–) or presence (+) of aerobactin. Proteins were detected by Western-blot using an anti-HA antibody. Position of the protein fragments (full length IutY and σIutY domain) and the molecular size marker (in kDa) are indicated.
Figure 4Dependency of constitutively active IutY point mutants on Prc, RseP, and IutA. (A) β-Galactosidase activity of the P. putida ΔiutY, ΔiutY Δprc, ΔiutY ΔrseP, and ΔiutY ΔiutA strains bearing the transcriptional fusion iutA::lacZ (pMPK4 plasmid) and the pMMBK1-HA (WT), pMMBK1-HA-R231Q, -F251S, -V253D, -W301G, or -LtoP construct expressing one of the IutY variants and grown in aerobactin-contained low iron medium with 1 mM IPTG. In each separate experiment the activity in the ΔiutY strain has been set to 100%. (B) The same strains were grown as above and the IutY proteins were detected by Western-blot using an anti-HA antibody. Position of the protein fragments (full length IutY and σIutY domain) and the molecular size marker (in kDa) are indicated.
Figure 5Conserved residues in . Alignment of the amino acid sequences of the periplasmic regions of all P. putida and P. aeruginosa CSS anti-sigma factors. Only residues identical in at least 50% of the sequences are shown. Fully conserved residues are shown in red, residues with strong similarity in green, and with weak similarity in blue. Conserved amino acids of which mutation in the P. putida IutY protein leads to constitutive activity are boxed, as well as amino acids that were mutated in the P. aeruginosa FoxR and FiuR proteins. Numbering indicates amino acid position in the P. putida IutY protein.
Figure 6Activity of the . β-Galactosidase activity of P. aeruginosa ΔfoxR bearing the transcriptional fusion foxA::lacZ (pMPR8b plasmid; left panel) or P. aeruginosa ΔfiuR bearing the transcriptional fusion fiuA::lacZ (pMPFiuA plasmid; right panel) and the pMMB67EH-derivate expressing the indicated HA-FoxR or HA-FiuR protein. Strains were grown in low iron medium in the absence (white bars) or presence (black bars) of 1 μM ferrioxamine or 40 μM ferrichrome, respectively.